Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01677741
Title A Study to Determine Safety, Tolerability and Pharmacokinetics of Oral Dabrafenib In Children and Adolescent Subjects
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications

melanoma

thyroid gland papillary carcinoma

high grade glioma

Advanced Solid Tumor

Therapies

Dabrafenib

Age Groups: child
Covered Countries USA | CAN

Additional content available in CKB BOOST